Mucosal distribution of infliximab in patients with Crohn's disease (CD).

被引：0
|
作者：
Geboes, K
Dalle, I
Baert, F
D'Haens, G
Cornillie, F
Rutgeerts, P
机构：
[1] Univ Hosp Sint Raphael, Louvain, Belgium
[2] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] Centocor Inc, Leiden, Netherlands
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1664
引用
收藏
页码：A322 / A322
页数：1
相关论文
共 50 条
  • [1] MUCOSAL HEALING IN PATIENTS TREATED WITH INFLIXIMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
    Boyd, J.
    Lee, L.
    Lanzon-Miller, S.
    GUT, 2013, 62
  • [2] Molecular mechanisms of infliximab response in Crohn's disease (CD) patients
    Mah, Nancy
    Pierrou, Stefan
    Hammer, Marten
    Nikolaus, Susanna
    Kuhbacher, Tanja
    Skogman, Eva
    Stalhult, Lars
    Astrand, Magnus
    Kerick, Martin
    Hasler, Robert
    Costello, Christine
    Thelin, Anders
    Mellgard, Bjorn
    Lagerstrom-Fermer, Maria
    Schreiber, Stefan
    GASTROENTEROLOGY, 2007, 132 (04) : A555 - A556
  • [3] Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease
    Danese, Silvio
    Fiorino, Gionata
    Vetrano, Stefania
    Rando, Giacomo
    Pagano, Nico
    Romeo, Fabio
    Omodei, Paolo
    Repici, Alessandro
    Rutella, Sergio
    Malesci, Alberto
    GASTROENTEROLOGY, 2009, 136 (05) : A558 - A558
  • [4] Monitoring a Combination of Calprotectin and Infliximab Identifies Patients With Mucosal Healing of Crohn's Disease
    Dreesen, Erwin
    Baert, Filip
    Laharie, David
    Bossuyt, Peter
    Bouhnik, Yoram
    Buisson, Anthony
    Lambrecht, Guy
    Louis, Edouard
    Oldenburg, Bas
    Pariente, Benjamin
    Pierik, Marieke
    van der Woude, C. Janneke
    D'Haens, Geert
    Vermeire, Severine
    Gils, Ann
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (03) : 637 - +
  • [5] Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease
    Hong, Sung Noh
    Song, Joo Hye
    Kim, Sung Jin
    Park, Yoon Ha
    Choi, Chang Wan
    Kim, Ji Eun
    Kim, Eun Ran
    Chang, Dong Kyung
    Kim, Young-Ho
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (02) : 313 - 322
  • [6] Desensitisation to infliximab in patients with Crohn's disease
    Lelong, J
    Duburque, C
    Fournier, C
    Colombel, JF
    Desreumaux, P
    Tonnel, AB
    Wallaert, B
    REVUE DES MALADIES RESPIRATOIRES, 2005, 22 (02) : 239 - 246
  • [7] Infliximab is Effective to Achieve Mucosal Healing in Children With Crohn's Disease
    Kierkus, Jaroslaw
    Dadalski, Maciej
    Szymanska, Edyta
    Wegner, Agnieszka
    Oracz, Grzegorz
    Ryzko, Jozef
    GASTROENTEROLOGY, 2011, 140 (05) : S513 - S513
  • [8] Serum infliximab levels and early mucosal healing in Crohn's disease
    Tang, J.
    Gao, X.
    Zhi, M.
    Zhou, H.
    Chen, H.
    Zhang, M.
    Yang, Q.
    Liang, Z.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S209 - S210
  • [9] Biomarker panel for prediction of mucosal healing in patients with Crohn's disease under infliximab therapy
    de Bruyn, M.
    Bessissow, T.
    Billiet, T.
    Cleynen, I.
    Kirkland, R.
    Liu, X.
    Hauenstein, S.
    Drake, K.
    Singh, S.
    Ferrante, M.
    Rutgeerts, P.
    Van Assche, G.
    Arijs, I.
    Opdenakker, G.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S45 - S46
  • [10] SERUM ONCOSTATIN M PREDICTS MUCOSAL HEALING IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB
    Bertani, L.
    Antonioli, L.
    Fornili, M.
    Fornai, M.
    Tapete, G.
    Albano, E.
    Svizzero, Baiano G.
    Ceccarelli, L.
    Mumolo, M. G.
    Baglietto, L.
    Marchi, S.
    Blandizzi, C.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S125 - S126
12345